Webjet (ASX:WEB) successfully prices 100m convertilble notes

02Jul

Webjet (ASX:WEB) successfully prices 100m convertilble notes

[videojs_hls url=’//du7x25at22z7c.cloudfront.net/276257/index_HLSv3.m3u8′ poster=’http://www.finnewsnetwork.com.au/newssystem/Headlines01_360_200702.jpg’]

 

Webjet (ASX:WEB) has successfully priced its €100 million, that’s around $1631 million, convertible notes due 2027.

The Notes will have a coupon of 2.50 per cent per annum, paid on a semi-annual basis.

The Notes will be cash-settled, with an initial conversion price of $4.09 per ordinary share.

The net proceeds are to be used to repay $50 million of the Company’s existing term debt whilst extending remaining term debt maturity into late 2022, as well as for potential acquisitions and ongoing capital management.

Shares in Webjet (ASX:WEB) are trading 1.96 per cent higher at $3.64.
 
Copyright 2020 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

15Dec

Cochlear (ASX:COH) reports US court upholds $US280m ruling

dd Mmm 2020 - Cochlear (ASX:COH) says the United States Supreme Court has denied Cochlear’s petition for review of the US Federal Circuit’s decision upholding a Judgment of USD $280 million in patent infringement damages against Cochlear in the lawsuit by the Alfred E. Mann Foundation for Scientific Research (“AMF”) and Advanced Bionics LLC (“AB”).

Read More
15Apr

Bank of Queensland (ASX:BOQ) restores regular dividend payment

15 Apr 2021 - Bank of Queensland (ASX:BOQ) has announced the company will restore its usual dividend payment on May 26 this year.

Read More
14Sep

Stocks of the Hour: Westpac, Cimic & HomeCo

14 Sep 2021 - A snapshot of the stocks on the move, featuring Westpac (ASX:WBC), Cimic (ASX:CIM) & HomeCo Daily Needs (ASX:HDN).

Read More
15Nov

ResApp Health (ASX:RAP) grants Sanofi an option to licence startup outcomes

15 Nov 2019 - Digital health company ResApp Health (ASX:RAP) has penned an agreement which grants Sanofi an exclusive license to use the outcomes generated under the Startup Creasphere incubator program.

Read More
29Aug

Stocks of the Hour: Galileo Mining, RAS Technology, Petratherm

29 Aug 2022 - A snapshot of the stocks on the move featuring Galileo Mining (ASX:GAL), RAS Technology (ASX:RTH) and Petratherm (ASX:PTR).

Read More
30Apr

Stocks of the Hour: Sihayo Gold, Argent Minerals, Oceana Lithium

30 Apr 2024 - A snapshot of the stocks on the move, featuring Sihayo Gold (ASX:SIH), Argent Minerals (ASX:ARD) and Oceana Lithium (ASX:OCN).

Read More
02Jul

Stocks of the Hour: Catapult (ASX:CAT), CIMIC (ASX:CIM), Westpac (ASX:WBC)

02 July 2021 - A snapshot of the news that broke today, featuring Catapult (ASX:CAT), CIMIC (ASX:CIM) & Westpac (WBC).

Read More
24Feb

Stocks of the Hour: Resource Base, AVITA Medical, Selfwealth

24 Feb 2023 - A snapshot of the stocks on the move featuring Resource Base (ASX:RBX), AVITA Medical (ASX:AVH) and Selfwealth (ASX:SWF).

Read More
14Mar

DGR Global (ASX:DGR) pens deal for Auburn Resources to acquire Armours Ripple Resources

12 Mar 2021 - DGR Global (ASX:DGR) has signed a deal with Auburn Resources and Armour Energy (ASX:AJQ) which will see Auburn acquire Armour’s wholly owned subsidiary, Ripple Resources.

Read More
09Apr

Mesoblast (ASX:MSB) see trials for COVID-19 lung distress

09 Apr 2020 - Mesoblast (ASX:MSB) today announced that its stem cell product candidate remestemcel-L will be formally evaluated in a randomized, placebo-controlled trial in patients with acute respiratory distress syndrome (ARDS) caused by coronavirus infection (COVID-19).

Read More